Health & Medications

GLP-1 Pills: Questions to Ask Before Switching From an Injection

By Owen Marsh / October 18, 2026 / Updated November 8, 2026

Glass of water beside assorted medicine tablets

If you take a weekly GLP-1 injection, a daily pill may sound easier. But a pill is not a simple swap. The medicine, the dose, the timing rules and the reason it was approved can all differ. As of 8 November 2026, the FDA (the U.S. Food and Drug Administration) has approved several GLP-1 tablets, each with its own label. This guide covers the labels, the early research and questions to bring to your doctor or pharmacist.

Key takeaways

Tablets and injections are separate products with separate labels. Their milligram numbers cannot be compared.
As of 8 November 2026, Wegovy tablets and Foundayo are approved for weight management. Rybelsus and Ozempic tablets are approved for type 2 diabetes.
Wegovy and the diabetes tablets need an empty stomach and a wait before eating. Foundayo can be taken with or without food.
Research on switching is early. One study had no comparison group, and the other was paid for by the maker of the pill it tested.
Whether, when and how to switch is a decision for your prescriber.

Which GLP-1 tablets are approved, as of 8 November 2026

GLP-1 is short for glucagon-like peptide-1. It is a hormone your gut releases after you eat. It helps the body handle blood sugar and helps you feel full. GLP-1 medicines copy that signal. Some are weekly injections. Others are tablets taken daily.

The table covers tablets whose labels I read on DailyMed, the U.S. National Library of Medicine’s drug-label collection. Labels change, so ask a pharmacist for the newest version.

Tablet (maker)	What the label says it is for	How it is taken	Dose steps on the label
Wegovy tablets (Novo Nordisk), label June 2026	Weight management in adults with obesity, or overweight plus a related condition. Also lowers heart-event risk in adults with heart disease.	Morning, empty stomach, up to 4 ounces of plain water, then wait 30 minutes before food, drink or other tablets	1.5 mg, 4 mg, then 9 mg, each for 30 days. From day 91, 25 mg.
Foundayo (Eli Lilly), label July 2026	Weight management in adults with obesity, or overweight plus a related condition. No blood sugar use is listed.	Once a day, with or without food	0.8 mg, 2.5 mg, then 5.5 mg, each for at least 30 days. Later steps up to 17.2 mg are possible.
Rybelsus tablets and Ozempic tablets (Novo Nordisk), one shared label, January 2026	Better blood sugar in adults with type 2 diabetes. Also lowers heart-event risk in those at high risk.	Same morning rules as Wegovy tablets	Rybelsus: 3 mg, 7 mg, then 7 or 14 mg. Ozempic tablets: 1.5 mg, 4 mg, then 4 or 9 mg.

Ozempic is now the name of an injection and also of a tablet. The tablet is a separate product that shares a label with Rybelsus. The Wegovy pill was approved on 22 December 2025, and Foundayo on 1 April 2026. New approvals can come at any time.

A pill is not the same dose in a new form

Injection and tablet doses are both written in milligrams, which can make them look comparable. The labels show they are not. Even the two Novo Nordisk diabetes tablets are not matched milligram for milligram. Nobody should convert between a tablet and an injection by arithmetic.

What the labels say about switching

Wegovy. The label describes moving from the 2.4 mg injection to the 25 mg tablet, starting one week after the last injection. It advises against combining Wegovy with other semaglutide products or any other GLP-1 medicine.
Rybelsus and Ozempic tablets. For people on the 0.5 mg Ozempic injection, the label describes starting a tablet one week after the last injection, at doses it names.
Foundayo. The label gives no steps for switching from other GLP-1 products. It does not recommend using it with another GLP-1 medicine.

These steps cover specific starting points. Yours may differ, so the plan has to come from your prescriber and not from a chart.

Safety warnings that stay with a pill

All three labels carry a boxed warning, the FDA’s strongest kind. In rodents, GLP-1 medicines caused a certain kind of thyroid tumor. Nobody knows whether this happens in people. People with a personal or family history of medullary thyroid cancer, or of an inherited condition called MEN 2, should not take these medicines.

The Wegovy and Foundayo labels also warn about pancreas inflammation, gallbladder problems, kidney injury after dehydration, and low blood sugar in people who also take insulin or a diabetes pill called a sulfonylurea. They ask you to tell your care team before surgery, because of a breathing risk during anesthesia.

What research says so far about switching

Two studies look at people who moved from injections to a pill. Neither settles the question.

OCTANE. Novo Nordisk announced this study on 30 September 2026. It was presented at the European diabetes research meeting (EASD) in Milan. Researchers looked back at records from a telehealth company, Ro, for 194 adults without diabetes or weight-loss surgery. All had switched from injectable semaglutide or tirzepatide to the Wegovy pill and stayed on it for three months. On average they lost 4.1 percent of body weight, about 8.8 pounds.

No group stayed on injections, so it cannot show whether switching works as well as continuing. Only people who stayed on the pill were counted, which can flatter the results. Novo Nordisk makes the pill and issued the announcement. I found it as a conference presentation, not a published journal paper.

ATTAIN-MAINTAIN. This was a randomized trial, meaning people were assigned by chance to a treatment or to a placebo, a dummy pill. It was published in Nature Medicine on 12 May 2026. It included 376 adults who had reached a plateau on weekly semaglutide or tirzepatide in an earlier trial. Over 52 weeks, those who switched to orforglipron kept about 79 percent of their earlier weight loss if they came from semaglutide, and about 75 percent if they came from tirzepatide. Placebo groups kept about 38 and 49 percent, in the same order. Average regain on the pill was about 1 kg (2.2 pounds) and 5 kg (11 pounds).

Eli Lilly paid for the trial and makes orforglipron. The lead author is a paid consultant to Lilly. In what I read, I found no study that compared switching with staying on the injection.

Your daily routine: timing, food and other medicines

For Wegovy tablets and the diabetes tablets, the labels describe the same steps:

Take one tablet in the morning, before eating or drinking anything.
Swallow it whole with no more than 4 ounces of plain water, about half a cup.
Wait at least 30 minutes before food, drink or any other tablet.
If you miss a dose, skip it and take the next one the following day.

Foundayo is different. Take it once a day, with or without food. If you miss a dose, take it as soon as you can, but do not double up. After seven or more missed doses in a row, the label says to restart at a lower dose.

If you take other tablets first thing, a 30-minute wait changes the order, so ask your pharmacist. Foundayo’s label also says slowed stomach emptying may change how other tablets are absorbed. It limits the cholesterol medicine simvastatin to 20 mg a day and names ritonavir as one to avoid. Tell your pharmacist about everything you take, including supplements.

Questions to bring to your appointment

Which tablet are you considering for me, and what is it approved for?
What do you expect to be better or worse than my injection?
When would my last injection be, and when would the first tablet start?
How does the morning rule fit with my other medicines?
Which side effects should make me call you, and who do I call after hours?
What will it cost each month, and does my plan cover it for my reason?

Checklist for the visit

A list of every medicine and supplement, with doses.
The name, dose and date of my last injection.
My usual morning routine and meal times.
My health history: thyroid, pancreas, gallbladder, kidney, eye and diabetes issues.
My insurance card, and someone to take notes.
A written plan with dates before I leave.

Frequently asked questions

Is a pill as strong as an injection?

I found no head-to-head study in what I read, and the doses are not comparable. Ask your doctor what to expect for you.

Can I take a pill and keep my injection?

The Wegovy and Foundayo labels do not recommend combining with another GLP-1 medicine. Ask your prescriber before taking both.

Will insurance cover the pill?

It varies by plan and may depend on the reason, such as weight or diabetes. I did not verify coverage. Ask your plan and pharmacist.

What if I have diabetes?

Rybelsus and Ozempic tablets are the ones approved for type 2 diabetes. The Wegovy and Foundayo labels are for weight management. Your doctor sets blood sugar plans and decides about other diabetes medicines.

Before you decide

Convenience is a good reason to ask, but it does not prove a switch suits you. The research is early and the labels differ. Do not start, stop or change a medicine because of this article. Bring your questions and the checklist, and let the person who knows your health history guide the plan.